Ligand Pharmaceuticals LGND Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Ligand Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's cash ratio?
- Ligand Pharmaceuticals (LGND) reported cash ratio of 2.8× in Q1 2026.
- How has Ligand Pharmaceuticals's cash ratio changed year-over-year?
- Ligand Pharmaceuticals's cash ratio increased by 246.1% year-over-year, from 0.8× to 2.8×.
- What is the long-term trend for Ligand Pharmaceuticals's cash ratio?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's cash ratio has grown at a 57.7% compound annual growth rate (CAGR), from 0.5× to 4.7×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.